TP53 and acute myeloid leukemia: They proposed a model of t-AML harboring clonal TP53 mutation that somatic TP53 mutations are present in the hematopoietic stem cells (HPSC) of some healthy individuals; and these HPSC may expand under the selective pressure of chemotherapy.